scispace - formally typeset
A

Anna Hardesty

Researcher at Brown University

Publications -  8
Citations -  64

Anna Hardesty is an academic researcher from Brown University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 6 publications receiving 11 citations.

Papers
More filters
Journal ArticleDOI

Use of anti-spike monoclonal antibodies in kidney transplant recipients with COVID-19: Efficacy, ethnic and racial disparities.

TL;DR: In this paper, the efficacy of passive immunization with anti-spike monoclonal antibodies (mAbs) was evaluated in decreasing hospitalizations or emergency room (ER) visits among kidney transplant recipients (KTR) with COVID-19.
Journal ArticleDOI

Validation of pneumonia prognostic scores in a statewide cohort of hospitalised patients with COVID-19.

TL;DR: Predictive performance of two recently developed COVID‐19‐specific prognostic tools, the CO VID‐GRAM and CALL scores, and prior prognostic scores for community‐acquired pneumonia, viral pneumonia and H1N1 influenza pneumonia in a contemporary US cohort are validated.
Journal ArticleDOI

Predictors of severity and mortality among patients hospitalized with COVID-19 in Rhode Island.

TL;DR: In this paper, the authors performed a retrospective cohort study of 259 patients admitted to our hospitals in Rhode Island to examine differences in baseline characteristics (demographics and comorbidities) as well as presenting symptoms, signs, labs, and imaging findings that predicted disease progression and in-hospital mortality.
Journal ArticleDOI

Coronavirus Disease 2019 in Kidney Transplant Recipients: Single-Center Experience and Case-Control Study.

TL;DR: In this paper, the authors describe their single-center experience with COVID-19 in KTR and compared the clinical course of KTR with non-transplant patients, matched by age and sex (controls).
Journal ArticleDOI

Comparison of COVID-19 outcomes in organ transplant recipients (OTr) and non-transplant patients: a study protocol for rapid review.

TL;DR: A rapid review of the available evidence on whether OTr diagnosed with COVID-19 are at higher risk for severe illness and death compared to non-immunocompromised individuals is presented in this paper.